Publication

  • Yang J, Ryan DJ, Wang W… Lu L, Liu P. (2017). Establishment in Culture of Mouse Expanded Potential Stem Cells. Nature, 550 (7676): 393-397. http://dx.doi.org/0.1038/nature24052
  • Sugimura R, Jha DK, Han A… Doulatov S, Daley GQ. (2017) Haematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells. Nature 545 (7655): 432–438. https://doi.org/10.1038/nature22370
  • Veerapandian V, Ackermann JO, Srivastava Y… Yang X, Jauch R. (2018) Directed Evolution of Reprogramming Factors by Cell Selection and Sequencing. Stem Cell Reports 11: 593-606. https://doi.org/10.1016/j.stemcr.2018.07.002
  • Ibarra-Soria X, Jawaid W, Pijuan-Sala B… Göttgens B*, Marioni JC*. (2018) Defining murine organogenesis at single-cell resolution reveals a role for the leukotriene pathway in regulating blood progenitor formation. Nat Cell Biol. 20(2): 127-134. (*Corresponding author) https://doi.org/10.1038/s41556-017-0013-z
  • Gao X, Nowak-Imialek M, Chen X… Niemann H, Liu P. (2019) Establishment of human and pig expanded potential stem cells uncovers conserved signaling requirements. Nature Cell Biology, 21(6): 687-699. http://dx.doi.org/10.1038/s41556-019-0333-2
  • Pijuan-Sala B, Gtiffiths JA, Guibentif C… Marioni JC, Göttgens B. (2019) A single-cell molecular map of mouse gastrulation and early organogenesis. Nature 566(7745) 490-495. https://doi.org/10.1038/s41586-019-0933-9
  • Huang R, Huang Y, Guo Y… Lu M, Li T. (2019) Systematic characterization and prediction of post-translational modification cross-talk between proteins. Bioinformatics 35 (15): 2626-2633. http://dx.doi.org/10.1093/bioinformatics/bty1033
  • Chen ACH, Peng Q, Fong SW, Yeung WSB, Lee YL. (2020) Sirt1 is regulated by miR-135a and involved in DNA damage repair during mouse cellular reprogramming. Aging (Albany NY) 12(8): 7431-7447. https://doi.org/10.18632/aging.103090

Publication

  • Yu Y, Tsang JC, Wang C… Dougan G, Liu P. (2016) Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway. Nature 29 (539): 102-106. https://doi.org/10.1038/nature20105
  • CY Tam, WMM Li, YP Gao… CS Lau and VSF Chan. (2017) Human CLEC16A regulates autophagy through modulating mTOR activity. Experimental Cell Research 352: 304-312.  https://doi.org/10.1016/j.yexcr.2017.02.017 
  • Lee JC, Biasci D, Roberts R… Mansfield  Parkes M and Smith KGC. (2017) Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease. Nat Genet 49(2), 262-268.  https://doi.org/10.1038/ng.3755 
  • Yang W, Garrett L, Feng D… Yang Y, Gao B. (2017) Wnt-induced Vangl2 phosphorylation is dose-dependently required for planar cell polarity in mammalian development. Cell Res 27 (12): 1466-1484.  https://doi.org/10.1038/cr.2017.127 
  • IKY Lam, JX Chow, CS Lau, VSF Chan. (2018) MicroRNA-mediated immune regulation in rheumatic diseases. Cancer Lett 9 (431): 201-212.  http://dx.doi.org/10.1016/j.canlet.2018.05.044  
  • Forbester JL, Lees EA, Goulding D… Powrie F, Dougan G. (2018) Interleukin-22 promotes phagolysosomal fusion to induce protection against Salmonella enterica Typhimurium in human epithelial cells. Proc Natl Acad Sci USA 115: 10118-10123. https://doi.org/10.1073/pnas.1811866115
  • Gao B, Ajima R, Yang W… Yamaguchi TP, Yang Y. (2018) Coordinated directional outgrowth and pattern formation by integration of Wnt5a and Fgfsignaling in planar cell polarity. Development 145 (8). https://doi.org/10.1242/dev.163824
  • Li PH, Wong WWY, Leung ENY, Lau CS, Au E. (2020) Novel mutations identified in the first Chinese pedigree of complete C6 deficiency. Clin Transl Immunology 9(7): e1148. https://doi.org/10.1002/cti2.1148 
  • Stewart BJ, Ferdinand JR, Clatworthy MR. (2020) Using single-cell technologies to map the human immune system – implications for nephrology. Nat Rev Nephrol. 16(2): 112-128. https://doi.org/10.1038/s41581-019-0227-3
  • Duque-Correa MA, Maizels RM, Grencis RK, Berriman M. (2020) Organoids - New Models for Host-Helminth Interactions. Trends Parasitol 36(2): 170-181. https://doi.org/10.1016/j.pt.2019.10.013

Official Collaborated with:

Green and blue abstract yin-yang like logo with text 'Centre for Translational Stem Cell Biology' and its Chinese translation.

Pipeline -

Body of water, Liquid, Blue, Vertebrate, Azure, Organism, Fluid, Aqua

New Stem Cell Technology

Taking advantage of totipotency features of Expanded Potential Stem Cells (EPSCs) and unique properties to development novel animal cloning technologs, CTSCB maps cell lineage atlas from human EPSCs to cell teypes relevant to regenerative medicine and immunotherapies. The new human cell lineage knowledge will directly inform the development of optimised protocols for efficient generation of specific cell types from human EPSCs.

More Info

Plant, Petal

EPSCs for Regenerative Medicine & Human Disease Study

Clinical grade Mesenchymal Stem Cells (MSCs) can be differentiated from human Expanded Potential Stem Cells (EPSCs) which are easier in culture, genetically and epigenetically stable, and allow more efficient genome-editing to generate modified MSCs that provide better therapeutic potential and further reduce their immune rejection after transplantation.

More Info

Water, Liquid, Purple, Petal, Flower, Organism, Violet, Pink, Magenta

EPSCs for Genomic Medicine of Immune Disease

CTSCB uses the Expanded Potential Stem Cells (EPSCs) technology to link genotype to phenotype through genetically defined stem cell-based models of human immune disease.

More Info

Scientists in white lab coats work at individual biosafety cabinets in a clean laboratory.

Learn more about our patented technology

Empowering the Future with Expanded Potential Stem Cells

We invent with EPSC Technology.

We invent with EPSC Technology.

Totipotency Features

EPSCs closely resemble early human embryos at the 8-cell to morula stage.

Genetically Stable

EPSCs are easy to generate, genetically stable, and highly reproducible.

Precise Genome Editing

EPSCs offer efficient genome editing, enabling breakthrough in targeted disease models, target validation, and personalized therapy. 

Personalized EPSCs

With a few drops of blood, we produce stem cells at scales large enough to benefit thousands.

Advanced Organoids

We use EPSCs to generate organoids that replicate human tissue, driving innovation in translational research.

Broad Application

EPSCs drive advances in regenerative medicine, drug discovery and cell therapy.

Unlocking EPSCs Capability

EPSCs closely resemble early human embryos at the 8-cell to morula stage and possess an extraordinary ability to generate both embryonic and extraembryonic lineages, including the placenta. This feature distinguishes EPSCs from other pluripotent stem cells.

With exceptional genetic and epigenetic stability, EPSC provides a reliable foundation for sustained research and therapeutic innovation. Their compatibility with precise genome editing technologies enables accelerated progress in studies of gene function and the development of targeted therapies.

How EPSCs help

Fluorescent green cell spheroid (organoid) surrounded by individual cells under a microscope.

Induced EPSC Colony

A representative image of an induced EPSC colony reprogrammed from a healthy donor, marked by Tra-1-60 (Green) for human pluripotency

Fluorescent image of cell clusters with green, purple, and blue stains, highlighting cellular structures.

Kidney Organoid

highlighting structures with various kidney cells – Nephrin (podocytes), PAX2 (collecting duct) with nuclear stain DAPI​​

A fluorescent microscopy image of a neural cell cluster with green neurites radiating from a magenta and blue core.

showing markers for dendritic neuron – MAP2 ​, spinal chord –Islet 1 with nuclear stain Hoechst​

MOTOR

NEURON

Motor Neuron

showing markers for dendritic neuron – MAP2 ​, spinal chord –Islet 1 with nuclear stain Hoechst​

Fluorescent image of a dense cell spheroid with blue nuclei, magenta cell boundaries, and internal red/green structures.

Heart Organoids

showing​ various cardiac structures - ACTB (cytoskeletal network), cTnT (mature cardiac cells), WGA27 (cell membrane) with nuclear stain DAPI​​

Fluorescent cells: blue nuclei, green cytoplasm, magenta structures.

AB-CAR-M

engulfing and breaking down liver cancer cells with nuclear stain DAPI

From the Lab to Real World Use

EPSCs can be derived from embryos or reprogrammed from somatic cells. We have established EPSCs in multiple species, including human, mouse, porcine, and bovine.

This next-generation stem cell technology continues to drive transformative advances in immunology, infectious disease modelling, regenerative medicine, and drug discovery, representing a significant step forward in translating stem cell science into real-world medical solutions.

Copyright ©2026 All rights reserved | InnoHK Centre for Translational Stem Cell Biology